Method for enhancing proliferation or differentiation of a cell using ob protein
US7074397B1 · kind B1 · utility
8Cited by
36References
37Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 20, 1996 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | Mar 15, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2264
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Uses for WSX ligands in hematopoiesis are disclosed. In particular, in vitro and in vivo methods for stimulating hematopoiesis (e.g., myelopoiesis, erythropoiesis and especially, lymphopoiesis) using a WSX ligand (e.g., anti-WSX receptor agonist antibodies or OB protein), and optionally another cytokine, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.